Pages that link to "Q34963520"

The following pages link to Mutant p53 Disrupts MCF-10A Cell Polarity in Three-dimensional Culture via Epithelial-to-mesenchymal Transitions (Q34963520):

Displaying 44 items.

• Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway (Q24302433) (← links)
• Succinate dehydrogenase 5 (SDH5) regulates glycogen synthase kinase 3β-β-catenin-mediated lung cancer metastasis (Q24320050) (← links)
• Mutant p53: One, No One, and One Hundred Thousand (Q26770576) (← links)
• The network of pluripotency, epithelial-mesenchymal transition, and prognosis of breast cancer (Q26785448) (← links)
• DEAR1, a novel tumor suppressor that regulates cell polarity and epithelial plasticity (Q26825789) (← links)
• Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition. (Q27333756) (← links)
• The rebel angel: mutant p53 as the driving oncogene in breast cancer (Q27686765) (← links)
• Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion (Q30537354) (← links)
• The role of MDM2 and MDM4 in breast cancer development and prevention. (Q33712095) (← links)
• PUMA Cooperates with p21 to Regulate Mammary Epithelial Morphogenesis and Epithelial-To-Mesenchymal Transition (Q34785360) (← links)
• The role of miR-200a in mammalian epithelial cell transformation (Q34917932) (← links)
• Mutant p53 cooperates with knockdown of endogenous wild-type p53 to disrupt tubulogenesis in Madin-Darby canine kidney cells (Q35081210) (← links)
• LAMC2 enhances the metastatic potential of lung adenocarcinoma (Q35829871) (← links)
• Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer. (Q35909576) (← links)
• P73 tumor suppressor and its targets, p21 and PUMA, are required for madin-darby canine kidney cell morphogenesis by maintaining an appropriate level of epithelial to mesenchymal transition (Q35987262) (← links)
• Mammary epithelial cell polarity is regulated differentially by p73 isoforms via epithelial-to-mesenchymal transition (Q36006937) (← links)
• Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53. (Q36070528) (← links)
• TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays (Q36376097) (← links)
• Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage (Q36413546) (← links)
• Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells. (Q36677712) (← links)
• P63 regulates tubular formation via epithelial-to-mesenchymal transition (Q36998524) (← links)
• Epstein-Barr virus latent membrane protein 2 effects on epithelial acinus development reveal distinct requirements for the PY and YEEA motifs (Q37336691) (← links)
• Effect of RhoC on the epithelial-mesenchymal transition process induced by TGF-β1 in lung adenocarcinoma cells (Q37419281) (← links)
• Mechanisms by Which the Extracellular Matrix and Integrin Signaling Act to Regulate the Switch Between Tumor Suppression and Tumor Promotion (Q37450854) (← links)
• Slug expression in mouse skin and skin tumors is not regulated by p53. (Q37625832) (← links)
• Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer (Q37991651) (← links)
• Epithelial to mesenchymal transition in the pathogenesis of uterine malignant mixed Müllerian tumours: the role of ubiquitin proteasome system and therapeutic opportunities (Q38000940) (← links)
• Tumour suppressor gene function in carcinoma-associated fibroblasts: from tumour cells via EMT and back again? (Q38164308) (← links)
• Mutant p53 in cancer: new functions and therapeutic opportunities (Q38197826) (← links)
• Three-dimensional cancer models mimic cell-matrix interactions in the tumour microenvironment. (Q38218018) (← links)
• p53 regulates cytoskeleton remodeling to suppress tumor progression (Q38553239) (← links)
• Mutant p53 promotes epithelial-mesenchymal plasticity and enhances metastasis in mammary carcinomas of WAP-T mice (Q38959098) (← links)
• Functions of the Tumor Suppressors p53 and Rb in Actin Cytoskeleton Remodeling (Q39080969) (← links)
• HuR is necessary for mammary epithelial cell proliferation and polarity at least in part via ΔNp63. (Q39267423) (← links)
• Differences in growth properties of endometrial cancer in three dimensional (3D) culture and 2D cell monolayer. (Q39269339) (← links)
• Cancer-specific mutations in p53 induce the translation of Δ160p53 promoting tumorigenesis (Q39323166) (← links)
• Identification of a novel p53 target, COL17A1, that inhibits breast cancer cell migration and invasion (Q41348871) (← links)
• Plakoglobin restores tumor suppressor activity of p53R175H mutant by sequestering the oncogenic potential of β-catenin. (Q55346775) (← links)
• Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cells. (Q55504431) (← links)
• MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer (Q64081418) (← links)
• TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer (Q93123334) (← links)
• Hotspot mutant p53-R273H inhibits KLF6 expression to promote cell migration and tumor metastasis (Q98177150) (← links)
• Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome (Q98280914) (← links)
• Mutant TP53 interacts with BCAR1 to contribute to cancer cell invasion (Q101216970) (← links)